ProCE Banner Activity

CCO Conference Highlights from the 2020 ESMO Virtual Congress

Slideset Download
Conference Coverage
Download this summary slideset that includes key data from studies in breast, lung, genitourinary, and gastrointestinal cancers presented at the 2020 ESMO Virtual Congress.

Released: October 23, 2020

Expiration: October 22, 2021

Share

Faculty

Yelena Y. Janjigian

Yelena Y. Janjigian, MD

Associate Attending Physician
Chief, 
Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medical College
New York, New York

Elizabeth Plimack

Elizabeth Plimack, MD, MS

Assistant Professor
Associate Member
Medical Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

Vamsidhar Velcheti

Vamsidhar Velcheti, MD

Professor of Medicine
NYU Grossman School of Medicine
Medical Director
Thoracic Oncology Program
Laura and Isaac Perlmutter Cancer Center
An NCI-designated Comprehensive Cancer Center
New York, New York 

Supporters

Supported by an educational grant from

Bristol Myers Squibb

Faculty Disclosure

Primary Author

Yelena Y. Janjigian, MD

Associate Attending Physician
Chief, 
Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medical College
New York, New York

Yelena Y. Janjigian, MD has disclosed that she has received funds for research support from Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Genentech/Roche, Lilly, and Merck; has received consulting fees from AstraZeneca, Bayer, Bristol-Myers Squibb, Daiichi-Sankyo, Imugene, Jounce, Lilly, Merck Serono, ONO, Pfizer, Seattle Genetics, and Zymeworks; and has ownership interest in Rgenix.

Elizabeth Plimack, MD, MS

Assistant Professor
Associate Member
Medical Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

Elizabeth R. Plimack, MD, MS, has disclosed that she has received funds for research support from Astellas, Bristol-Myers Squibb, Genentech, and Merck; has received fees for non-CME/CE services (scientific advisory board) from Bristol-Myers Squibb, Genentech, Merck and Seattle Genetics; has received fees for non-CME/CE services (DSMBs) from AstraZeneca, Infinity Pharma, and Pfizer.

Vamsidhar Velcheti, MD

Professor of Medicine
NYU Grossman School of Medicine
Medical Director
Thoracic Oncology Program
Laura and Isaac Perlmutter Cancer Center
An NCI-designated Comprehensive Cancer Center
New York, New York 

Vamsidhar Velcheti, MD, has disclosed that he has received consulting fees from AstraZeneca, Bristol-Myers Squibb, EMD Serono, Foundation Medicine, and Merck.